- Home
- GPRO vs XBIT Comparison
GPRO vs XBIT Comparison
Compare GPRO & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPRO
- XBIT
- Stock Information
- Founded
- GPRO 2004
- XBIT 2005
- Country
- GPRO United States
- XBIT United States
- Employees
- GPRO N/A
- XBIT N/A
- Industry
- GPRO Industrial Machinery/Components
- XBIT Pharmaceuticals and Biotechnology
- Sector
- GPRO Consumer Discretionary
- XBIT Health Care
- Exchange
- GPRO Nasdaq
- XBIT Nasdaq
- Market Cap
- GPRO 193.5M
- XBIT 194.5M
- IPO Year
- GPRO 2014
- XBIT 2015
- Fundamental
- Price
- GPRO $1.05
- XBIT $3.82
- Analyst Decision
- GPRO Hold
- XBIT
- Analyst Count
- GPRO 1
- XBIT 0
- Target Price
- GPRO $1.50
- XBIT N/A
- AVG Volume (30 Days)
- GPRO 1.5M
- XBIT 94.1K
- Earning Date
- GPRO 02-05-2025
- XBIT 11-13-2024
- Dividend Yield
- GPRO N/A
- XBIT N/A
- EPS Growth
- GPRO N/A
- XBIT N/A
- EPS
- GPRO N/A
- XBIT N/A
- Revenue
- GPRO $896,011,000.00
- XBIT N/A
- Revenue This Year
- GPRO N/A
- XBIT N/A
- Revenue Next Year
- GPRO N/A
- XBIT N/A
- P/E Ratio
- GPRO N/A
- XBIT N/A
- Revenue Growth
- GPRO N/A
- XBIT N/A
- 52 Week Low
- GPRO $1.03
- XBIT $3.51
- 52 Week High
- GPRO $3.40
- XBIT $9.96
- Technical
- Relative Strength Index (RSI)
- GPRO 36.42
- XBIT 32.16
- Support Level
- GPRO $1.03
- XBIT $3.64
- Resistance Level
- GPRO $1.19
- XBIT $4.00
- Average True Range (ATR)
- GPRO 0.04
- XBIT 0.34
- MACD
- GPRO -0.00
- XBIT 0.02
- Stochastic Oscillator
- GPRO 12.90
- XBIT 17.48
About GPRO GoPro Inc.
GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts, drones and appliances. The company outsources a part of manufacturing to third parties in China. The company sells products across the world through its direct sales channel, which generates over half of total revenue, and indirectly through its distribution channel. The company has presence, including in the Americas, Europe, Middle East, Africa, and Asia-Pacific, with the Americas contributing over half of total revenue.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.